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Introduction
Neutropenic enterocolitis (NE), first described by
Wagner in 1970, is a well recognized clinicopathologic
and life-threatening gastrointestinal complication of
chemotherapy for hematologic and solid malignan-
cies. Early recognition and treatment are essential for
survival. Even with the currently recommended ther-
apy, there is still a high mortality rate, with approxi-
mately 45% of NE often occurring 10–14 days after
initiation of cytotoxic chemotherapy. In most patients,
the symptoms resolve after correction of the neutrope-
nia. There is general agreement that early management
should be conservative, consisting of bowel rest, intra-
venous fluid administration, total parenteral nutrition,
broad-spectrum antibiotics, and normalization of neu-
trophil counts. Surgical intervention is only warranted
in the setting of intestinal perforation, obstruction, cli-
nical deterioration during conservative management
suggestive of uncontrolled sepsis, and persistent gas-
trointestinal bleeding despite correction of cytopenias
and coagulopathy.
Case Report
A 62-year-old female with a 2-year history of essential
hypertension presented with gum swelling, dizziness,
weight loss, and multiple non-tenderness neck lym-
phadenopathy of 1-month duration. Bone marrow 
examination (Figure 1), peripheral blood smear, and
flow cytometry confirmed the diagnosis of acute
monoblastic leukemia M5a. Induction chemotherapy
with intravenous 1-beta-D-arabinofuranosylcytosine
(ara-C) plus idarubicin was administered, with complete
remission attained 14 days later.
Sudden onset of right lower quadrant abdominal
pain associated with fever, nausea, abdominal fullness,
poor appetite, and rebound tenderness occurred on the
13th day of initiation of chemotherapy, which was the
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first cycle of consolidation chemotherapy with ara-C
(100 mg/m2) and idarubicin (12 mg/m2). She did not
have melena or bloody stool at that time.
Her white blood cell count was 200/µL but with 
no detectable neutrophils, the hemoglobin level was
9.1 g/dL, platelet 46,000/µL, and serum C-reactive pro-
tein 7.1 mg/dL. Abdominal X-ray (Figure 2) showed
small bowel loop distension with mucosal thickening
and fluid collection between bowel loops. Abdominal
computed tomography (Figure 3) revealed small intes-
tine dilation and marked wall thickening with target
sign involving the entire ascending colon. The blood
culture revealed Enterobacter cloacae, whereas the stool
specimen revealed no significant findings, except posi-
tive occult blood. These findings supported the diag-
nosis of NE with Enterobacter cloacae septicemia.
She started to recover on the ninth day after con-
servative management comprising intensive supportive
care with isolation, bowel rest, nasogastric suction, intra-
venous fluid administration, granulocyte-colony stim-
ulating factor, meropenem, and metronidazole, and
she was finally discharged from hospital.
Discussion
NE or typhlitis is an uncommon but highly mortal
complication, the incidence rate of which is about
0.1–26%1–3 after receiving chemotherapy4 and mor-
tality rate 50% or higher5–8. It can occur in a variety 
of diseases, including acute leukemia following che-
motherapy, chronic leukemia9, lymphoma10, multiple
myeloma11, solid tumors12, aplastic anemia13, tha-
lassemia minor14, cyclic neutropenia7, agranulocy-
tosis15, systemic lupus erythematosus5, and HIV
infection1. However, the symptoms often occur 10–14
days after initiation of cytotoxic chemotherapy16. There-
fore, we should be alert to the possibility of this dis-
ease in leukemia, with acute abdominal pain 10–14
days after chemotherapy as it was in our case.
The diagnostic criteria are heterogeneous and were
not documented until 2005 when a review on the sys-
tematic analysis of evidence quality of NE suggested
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Figure 3. Contrast-enhanced computed tomography of the
abdomen demonstrates target sign (arrow) involving the
entire ascending colon. Small intestine shows luminal
dilatation and submucosal edema.
Figure 1. Bone marrow smear demonstrates poorly differen-
tiated large blasts with abundant cytoplasm and occasional
mitoses.
Figure 2. Plain film of the abdomen demonstrates small
bowel loop distension with mucosal thickening.
that the definitive criteria should include fever,
abdominal pain, and bowel wall thickening of more
than 4 mm demonstrated by computed tomography
or ultrasound in a neutropenic patient17. Although the
criterion of the radiologic definition may need more
investigation to warrant its accuracy, it is essential to
restrict the diagnosis of NE to severe invasive infec-
tions, because the course and prognosis are totally 
different between superficial infections without pene-
tration of basal membranes and infections with 
involvement of deeper layers of the bowel wall18. The
abdominal computed tomography in our case revealed
mucosal edema involving both small and large intes-
tines, which was convincing evidence that infection
involved deep mucosa.
Because NE could be one of the non-surgical con-
ditions in acute abdomen19–21, it is important to avoid
unnecessary invasive intervention, especially in neutro-
penic patients. Since NE frequently involves the cecum
because of its relatively lower blood flow and greater
distensibility resulting in increased stasis of luminal
contents22, abdominal pain on the right lower quadrant
is the most prevalent presentation. The differential
diagnosis of right lower quadrant abdominal pain in
neutropenic patient should include NE, appendicitis,
ischemic bowel disease, bowel perforation/obstruction,
tumor bleeding, incarcerated hernia, pelvic abscess,
pseudomembranous colitis, and intussusception, some
of which are surgical conditions, thus making the inter-
vention decision difficult23–24. The differential diagno-
sis is important, because surgical intervention should
be performed in appendicitis or ischemic bowel dis-
ease with perforation. However, NE should be treated
by non-surgical management. The differential diagno-
sis should depend on detailed history taking, physical
examination, and imaging study, of which ultrasound
or computed tomography scans are the best radi-
ographic studies to confirm the diagnosis; but barium
enema and colonoscopy can be hazardous and may be
contraindicated as they can precipitate perforation1.
The conservative management of NE includes bowel
rest, nasogastric suction, total parenteral nutrition,
and broad-spectrum antibiotic therapy. The antibiotic
should cover Clostridium difficile before pseudomem-
branous colitis is excluded. Furthermore, cytopenias and
coagulopathy should be corrected. Recombinant gran-
ulocyte colony-stimulating factor has been used to has-
ten recovery. In most patients, the symptoms resolve
after correction of the neutropenia1.
Surgical intervention for NE is suggested for per-
sistent gastrointestinal bleeding despite correction of
cytopenias and coagulopathy, intra-abdominal perfo-
ration and clinical deterioration despite aggressive
supportive therapy, difficulty in differentiation from
other acute abdominal diseases, and signs of localized
peritonitis persisting regardless of the resolution of
neutropenia25.
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